![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, January 09, 2005 1:24:23 PM
BOBERG: I would say that few companies have the same high technological ability of gene expression as Global Genomics, although many companies do compete with Affymetrix in the microarray space. In the open system competitive space, there is one company called Biofrontera that uses their technology for in-house development, but have chosen not to market their technology for strategic reasons. There are few open gene expression systems with similar sensitivity and reliability as tangerine profiling.
Sounds like there is a market for the DEPD technology itself if Biofrontera/DNAPrint wish to pursue it.
Interesting audio interview on the subject, done on April 6, 2004 at this link:
http://64.233.167.104/search?q=cache:cFSCbA57X30J:www.wallstreetreporter.com/linked/GlobalGenomics.h....
Later,
W2P
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM